Quality-by-design of nanopharmaceuticals - a state of the art.
暂无分享,去创建一个
[1] M. Khan,et al. Quality by design: understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box-Behnken design and desirability function. , 2007, International journal of pharmaceutics.
[2] Diane J Burgess,et al. Quality by design approach to understand the process of nanosuspension preparation. , 2009, International journal of pharmaceutics.
[3] H. Schneider. Failure mode and effect analysis : FMEA from theory to execution , 1996 .
[4] G. Peter Christoper,et al. Formulation and optimization of coated PLGA - Zidovudine nanoparticles using factorial design and in vitro in vivo evaluations to determine brain targeting efficiency. , 2014, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.
[5] Diane J Burgess,et al. Quality by Design approach to spray drying processing of crystalline nanosuspensions. , 2014, International journal of pharmaceutics.
[6] Sanchoy K. Das,et al. A concurrent engineering approach for the development of medical devices , 2000, Int. J. Comput. Integr. Manuf..
[7] Min-Soo Kim,et al. Quality by design: screening of critical variables and formulation optimization of Eudragit E nanoparticles containing dutasteride , 2013, Archives of pharmacal research.
[8] J. Benneyan,et al. Statistical process control as a tool for research and healthcare improvement , 2003, Quality & safety in health care.
[9] V. Pokharkar,et al. Quality by design approach to understand the process of optimization of iloperidone nanostructured lipid carriers for oral bioavailability enhancement , 2015, Pharmaceutical development and technology.
[10] T. C. Powell. Total Quality Management as Competitive Advantage , 1995 .
[11] Edward D. Arnheiter,et al. The integration of lean management and Six Sigma , 2005 .
[12] Hazem Ali,et al. Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model. , 2013, International journal of pharmaceutics.
[13] Ziyaur Rahman,et al. Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman design. , 2010, International journal of pharmaceutics.
[14] Joseph Moses Juran. Juran on Quality by Design: The New Steps for Planning Quality into Goods and Services , 1992 .
[15] Theodora Kourti,et al. Multivariate SPC Methods for Process and Product Monitoring , 1996 .
[16] M. van de Weert,et al. Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approach. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[17] Harish Padh,et al. Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: Effect on formulation and characterization parameters. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[18] Sarsvatkumar Patel,et al. Novel lipid based oral formulation of curcumin: development and optimization by design of experiments approach. , 2012, International journal of pharmaceutics.
[19] I. Ghosh,et al. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[20] Edina Pallagi,et al. Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation. , 2015, International journal of pharmaceutics.
[21] F. Guillemin,et al. Improvement of meta-tetra(hydroxyphenyl)chlorin-like photosensitizer selectivity with folate-based targeted delivery. synthesis and in vivo delivery studies. , 2008, Journal of medicinal chemistry.
[22] S. Singh,et al. Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach. , 2016, International journal of biological macromolecules.
[23] Levy Batista,et al. A comparison of methods for delineation of wave boundaries in 12 lead ECG , 2017 .
[24] T. Bastogne,et al. Rational design of an arene ruthenium chlorin conjugate for in vivo anticancer activity , 2014 .
[25] Kaisar Raza,et al. Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne. , 2013, Colloids and surfaces. B, Biointerfaces.
[26] Hu Zhang,et al. Quality by design for biopharmaceuticals: a historical review and guide for implementation , 2013 .
[27] Kai Yang,et al. Design for Six Sigma , 2005 .
[28] S. Chitlange,et al. Application of quality by design approach to optimize process and formulation parameters of rizatriptan loaded chitosan nanoparticles , 2015, Journal of advanced pharmaceutical technology & research.
[29] Levy Batista,et al. Comparison of compression methods for impedance and field potential signals of cardiomyocytes , 2017, 2017 Computing in Cardiology (CinC).
[30] A. Rathore,et al. Quality by design for biopharmaceuticals , 2009, Nature Biotechnology.
[31] I. Ghosh,et al. Influence of Critical Parameters of Nanosuspension Formulation on the Permeability of a Poorly Soluble Drug through the Skin—A Case Study , 2013, AAPS PharmSciTech.
[32] M. Brandl,et al. Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[33] Bhupinder Singh,et al. Positively charged self-nanoemulsifying oily formulations of olmesartan medoxomil: Systematic development, in vitro, ex vivo and in vivo evaluation. , 2015, International journal of pharmaceutics.
[34] Douglas C. Montgomery,et al. Research Issues and Ideas in Statistical Process Control , 1999 .
[35] J. Lovrić,et al. Nanotherapeutics in the EU: an overview on current state and future directions , 2014, International journal of nanomedicine.
[36] F. Guillemin,et al. Response surface methodology: an extensive potential to optimize in vivo photodynamic therapy conditions. , 2009, International journal of radiation oncology, biology, physics.
[37] Roger Phan-Tan-Luu,et al. Pharmaceutical Experimental Design , 1998 .
[38] Hanne Mørck Nielsen,et al. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[39] V. Nekkanti,et al. Media milling process optimization for manufacture of drug nanoparticles using design of experiments (DOE) , 2015, Drug Development and Industrial Pharmacy.
[40] Y. Wang,et al. Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension. , 2010, International journal of pharmaceutics.
[41] Xingyou Ye,et al. Continuous Production of Fenofibrate Solid Lipid Nanoparticles by Hot-Melt Extrusion Technology: a Systematic Study Based on a Quality by Design Approach , 2014, The AAPS Journal.